Humana price target lowered to $258 from $310 at Mizuho

Mizuho lowered the firm’s price target on Humana (HUM) to $258 from $310 and keeps an Outperform rating on the shares. The firm says Humana is most debated stock in its healthcare universe. It believes the company “stands out as one of the most compelling stocks” in managed care. Humana’s risk/ reward is attractive at current levels, the analyst tells investors in a research note.